Arotinolol hydrochloride

Adriforant hydrochloride (PF-3893787 hydrochloride) is a novel histamine H4 receptor antagonist binding affinity ( K i =2.4 nM) and is also a functional ( K i =1.56 nM) antagonist.In VitroAdriforant is tested and observed binding K i =2.4 nM and

Adriforant hydrochloride (PF-3893787 hydrochloride) is a novel histamine H4 receptor antagonist binding affinity ( K i =2.4 nM) and is also a functional ( K i =1.56 nM) antagonist.In VitroAdriforant is tested and observed binding K i =2.4 nM and

Adriforant hydrochloride (PF-3893787 hydrochloride) is a novel histamine H4 receptor antagonist binding affinity ( K i =2.4 nM) and is also a functional ( K i =1.56 nM) antagonist.In VitroAdriforant is tested and observed binding K i =2.4 nM and

Adriforant hydrochloride (PF-3893787 hydrochloride) is a novel histamine H4 receptor antagonist binding affinity ( K i =2.4 nM) and is also a functional ( K i =1.56 nM) antagonist.In VitroAdriforant is tested and observed binding K i =2.4 nM and

Adriforant hydrochloride (PF-3893787 hydrochloride) is a novel histamine H4 receptor antagonist binding affinity ( K i =2.4 nM) and is also a functional ( K i =1.56 nM) antagonist.In VitroAdriforant is tested and observed binding K i =2.4 nM and

Adrenergic receptors (ARs) belong to the 7-transmembrane domain G protein-coupled receptor superfamily that binds to the endogenous catecholamines, epinephrine and norepinephrine. &#945 2 AR subtypes block adenylyl cyclase, suppress

Anti-ARL14EP ADP-ribosylation factor-like 14 effector protei

Anti-ARL14EP ADP-ribosylation factor-like 14 effector protei

CGP 12177 hydrochloride is a β1-AR and β2-AR adrenoreceptor antagonist. Also behaves non-conventionally as a β3-AR partial agonist.

CGP 12177 hydrochloride is a β1-AR and β2-AR adrenoreceptor antagonist. Also behaves non-conventionally as a β3-AR partial agonist.

EVAHL System, EVAHL1, EVABELT1, EVAHLBAT1, PA1AFI, PAFLEXBT,

JP 1302 dihydrochloride is a potent and selective α2C-AR adrenoreceptor antagonist. JP 1302 dihydrochloride strongly antagonizes adrenaline-stimulated 35GTPγS binding|in vitro|.